USFDA decision on Eisai, Biogen Alzheimer's drug due in January Ruchika Sharma6 July 2022 10:00 AM ISTEisai in March downsized its role in Aduhelm, but remains the leader in the 50-50 partnership's lecanemab program.
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US Ruchika Sharma5 Jun 2022 9:00 AM ISTBYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.
Biogen CEO to step down as drugmaker pulls back from Alzheimer's drug Aduhelm Ruchika Sharma4 May 2022 11:30 AM ISTBiogen said on Tuesday it was looking at "substantially" eliminating commercial infrastructure related to Aduhelm and plans for more cost cuts, in...
Biogen shares slide as Medicare restricts cover of Alzheimer's treatments Ruchika Sharma13 Jan 2022 9:00 AM ISTNew Delhi: A decision by the US Medicare to limit coverage of Alzheimer's treatments including Biogen's Aduhelm will hit sales of the controversial...
Biogen gets USFDA Fast Track designation for lecanemab Ruchika Sharma26 Dec 2021 9:30 AM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the...
Setback: Biogen loses bid to revive patent on Mylan blockbuster MS drug Tecfidera Ruchika Sharma3 Dec 2021 5:07 PM ISTTecfidera, on the market since 2013, has been key to Biogen's fortunes while it struggles to find new medicines to make up for declining revenue.
Alzheimer's drug price will be competitive: Roche executive Ruchika Sharma13 Nov 2021 10:00 AM ISTNew Delhi: Roche Holding AG, still months away from seeking regulatory approval of its experimental Alzheimer's drug, is already taking aim at rival...
Despite ALS drug trial failing main goal, Biogen says data are encouraging Ruchika Sharma18 Oct 2021 1:02 PM ISTNew Delhi: A late-stage trial of Biogen Inc's experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its...
Biogen Alzheimer's drug: Former FDA adviser calls for wider probe into approval Ruchika Sharma21 July 2021 2:00 PM ISTNew Delhi: A federal probe of the U.S. Food and Drug Administration's approval of a controversial new Alzheimer's disease drug should look into why...
Biogen, Eisai secure USFDA accelerated nod for Alzheimer drug ADUHELM Ruchika Sharma8 Jun 2021 3:57 PM ISTCambridge: Biogen and Eisai, Co., Ltd. have announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...
Glenmark gets USFDA approval for Dimethyl Fumarate Delayed-Release Capsules Ruchika Sharma7 Oct 2020 3:13 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA today announced that the company has been granted final approval by the United States Food & Drug...
Lupin gets USFDA nod to generic equivalent of Tecfidera Delayed-Release Capsules Ruchika Sharma7 Oct 2020 12:31 PM ISTMumbai, Baltimore: Pharma major, Lupin Limited, has recently announced that the company has received approval for its Dimethyl Fumarate...
